AU2023225805A1 — Methods for viral infections
Assigned to Jericho Sciences LLC · Expires 2024-10-17 · 2y expired
What this patent protects
The present invention relates to methods of treating lentivirus and other viral infections. Viral zinc finger domains are considered critical targets across multiple virus families, as they are highly mutationally restricted and serve critical roles in both virus replication and …
USPTO Abstract
The present invention relates to methods of treating lentivirus and other viral infections. Viral zinc finger domains are considered critical targets across multiple virus families, as they are highly mutationally restricted and serve critical roles in both virus replication and in virus-host interactions, which are the sabotaging interactions that can cause complications of inflammation and immune dysregulation. Human immunodeficiency virus mutates faster than any other known virus, establishing precedence for other potential virus infection indications.
Drugs covered by this patent
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.